The impact of comorbidity on health-related quality of life in elderly patients with chronic myeloid leukemia.
about
Variables associated with patient-reported outcomes in persons with chronic myeloid leukemia receiving tyrosine kinase-inhibitor therapy.Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome.Higher out-of-pocket expenses for tyrosine kinase-inhibitor therapy is associated with worse health-related quality-of-life in persons with chronic myeloid leukemia.Achieving optimal response at 12 months is associated with a better health-related quality of life in patients with chronic myeloid leukemia: a prospective, longitudinal, single center study
P2860
The impact of comorbidity on health-related quality of life in elderly patients with chronic myeloid leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The impact of comorbidity on h ...... with chronic myeloid leukemia.
@en
type
label
The impact of comorbidity on h ...... with chronic myeloid leukemia.
@en
prefLabel
The impact of comorbidity on h ...... with chronic myeloid leukemia.
@en
P2093
P2860
P50
P1433
P1476
The impact of comorbidity on h ...... with chronic myeloid leukemia.
@en
P2093
A Russo Rossi
F Efficace
F Mandelli
M Baccarani
M Bergamaschi
P2860
P304
P356
10.1007/S00277-015-2541-6
P577
2015-11-07T00:00:00Z